Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : NVSEF save search
Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
Published: 2022-03-15 (Crawled : 21:00) - globenewswire.com
MOLN | $3.88 -3.54% 200
|
Professional, Scientific, and T...
|
| O: -0.2%
H: 0.24%
C: -0.46%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 2.25%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
als report molecular
Radiopharmaceuticals Market Size to Grow by USD 4.37 Bn| 44% of the growth to originate from North America| Technavio
Published: 2022-03-14 (Crawled : 12:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -3.28%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
FUSN | $21.4 -0.09% -0.09% 270K
|
Health Technology
|
| O: -0.14%
H: 0.34%
C: 0.34%
america als origin growth
Dermatologicals Market to Reach $59.30 Bn, Globally, by 2030 at 11.50% CAGR: AMR
Published: 2022-02-21 (Crawled : 13:30) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
als dermatological derm
Bronchoscopes Market is Anticipated to Surge at a CAGR of 7.43% and is Also Contemplated to Reach USD 27.48 Billion by 2026, Analyzes DelveInsight
Published: 2022-02-04 (Crawled : 17:00) - prnewswire.com
TFX | $211.17 0.03% 1.34% 200K
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
SYK | $336.85 0.58% 0.0% 1.5M
|
Health Technology
|
| O: -1.59%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.24%
H: 0.0%
C: 0.0%
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
BDX | $233.83 -0.23% 3.49% 780K
|
Health Technology
|
| O: -1.41%
H: 0.0%
C: 0.0%
als
Non-alcoholic Steatohepatitis Clinical Trials Market Size Worth $4.2 Billion By 2030: Grand View Research, Inc.
Published: 2022-02-01 (Crawled : 11:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 3.58%
H: 0.0%
C: -1.59%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 2.5%
H: 0.0%
C: 0.0%
ICLR | News | $308.79 0.76% 0.76% 960K
|
Health Technology
|
| O: 0.89%
H: 0.59%
C: 0.41%
hepatitis als trials research trial clinical trials
Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent
Published: 2022-01-04 (Crawled : 07:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.17%
H: 0.12%
C: -0.62%
gilenya novartis als patent
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.